Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.32 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.32 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.32 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18849973 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL18849972 | 1.00 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821747 | 0.99 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821781 | 0.99 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821879 | 0.98 | KDM4E (0.35) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821808 | 0.98 | KDM4E (0.36) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821832 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821784 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL20821854 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1PTGER4PLA2G2A | |
| SCHEMBL22267441 | 0.97 | KDM4E (0.34) | KDM4EATML3MBTL1PTGER4PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200270235-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-08-27 | — | — | US | disclosed |
| US-10723722-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2020-07-28 | — | — | US | disclosed |
| EP-3371274-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-08-21 | — | — | EP | disclosed |
| US-20190084967-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-03-21 | — | — | US | disclosed |
| WO-2017076485-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200270235-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EED, MT-CO3, MT-ND5 | KDM4E 1811/4885ATM 4087/4885L3MBTL1 1847/4885 |
| US-20190084967-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EED, MT-CO3, MT-ND5 | KDM4E 1811/4885ATM 4087/4885L3MBTL1 1847/4885 |
| US-10723722-B2 | Materials for organic electroluminescent devices | CYCS, MT-CO3, EED | KDM4E 2375/4885ATM 4310/4885L3MBTL1 2132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.